Evaluation of HSV-tk gene therapy in a rat model of chemically induced hepatocellular carcinoma by intratumoral and intrahepatic artery routes

Cancer Research

Volumn 60, Issue 4, 2000, Pages 993-1001

  Gerolami, René ^a   Cardoso, Jorge ^b   Lewin, Maïté ^a   Bralet, Marie Pierre ^c   Sa Cunha, Antonio ^a   Clément, Olivier ^a   Bréchot, Christian ^a   Tran, Phuong Lan ^a,d  

^a INSERM   (France)

^b Université Paris Descartes   (France)

^c BEAUJON HOSPITAL   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLNITROSAMINE; GANCICLOVIR; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HEPATIC ARTERY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR GROWTH; TUMOR VOLUME;

ADENOVIRIDAE; ANIMALS; DIETHYLNITROSAMINE; GANCICLOVIR; GENE THERAPY; HEPATIC ARTERY; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; RATS; RATS, WISTAR; SIMPLEXVIRUS; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

EID: 0034652614     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Freeman, S. M., Abboud, C. N., Whartenby, K. A., Packman, C. H., Koeplin, D. S., Moolten, F. L., and Abraham, G. N. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res., 53: 5274-5283, 1993.
2. Caruso, M., Panis, Y., Gagandeep, S., Houssin, D., Salzmann, J. L., and Klatzmann, D. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc. Natl. Acad. Sci. USA, 90: 7024-7028, 1993.
3. Kaneko, S., Hallenbeck, P., Kotani, T., Nakabayashi, H., McGarrity, G., Tamaoki, T., Anderson, W. F., and Chiang, Y. L. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression. Cancer Res., 55: 5283-5287, 1995.
4. Wills, K. N., Huang W-M., Harris, M. P., Machemer, T., Maneval, D. C., and Gregory, R. J. Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene. Cancer Gene Ther., 2: 191-197, 1995.
5. Qian, C., Idoate, M., Bilbao, R., Sangro, B., Bruna. O., Vasquez, J., and Prieto, J. Gene transfer and therapy with adenoviral vector in rats with diethylnitrosamine-induced hepatocellular carcinoma. Hum. Gene Ther., 8: 349-358, 1997.
6. Cao, G., Kuryiama, S., Du, P., Sakamoto, T., Kong, X., Masui, K., and Qi, Z. Complete regression of established murine hepatocellular carcinoma by in vivo tumor necrosis factor α gene transfer. Gastroenterology, 112: 501-510, 1997.
7. INK4/CDKN2 and p53 genes cooperate to induce apoptic tumor cell death. Nat. Med., 3: 313-319, 1997.
8. Anderson, S. C. A., Johnson, D. E., Harris, M. P., Engler, H., Hancok, W., Huang, W-M., Wills, K. N., Gregory, R. J., Sutjipto, S., Wen, S. F., Lofgren, S., Shepard, H. M., and Maneval, D. C. p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus. Clin. Cancer Res., 4: 1649-1659, 1998.
9. Gagandeep, S., Brew, R., Green, B., Christmas, S. E., Klatzmann, D., Poslon, G. J., and Kinsella, A. R. Prodrug-activated gene therapy: involvement of an immunological component in the "bystander effect". Cancer Gene Ther., 3: 83-88, 1996.
10. Colombo, M. Hepatocellular carcinoma. J. Hepatol., 15: 225-236, 1992.
11. Okuda, K. Hepatocellular carcinoma: recent progress. Hepatology, 15: 948-963, 1992.
12. Breedis, C., and Young. G. Blood supply of neoplasms in the liver. Am. J. Pathol., 30: 969-985, 1954.
13. Taniguchi, T., Daidoh, T., Shioaki. Y., and Takahashi, T. Blood supply and drug delivery to primary and human lixer cancers studied with in vivo bromodeoxyuridine labeling. Cancer (Phila.), 71: 5055, 1993.
14. Schaffner, F., and Popper, H. Capillarization of hepatic sinusoids in man. Gastroenterology, 44: 239-242, 1983.
15. Yamamoto, T., Kaneda, K., Hirobashi, K., Kinoshita, H., and Sakurai, M. Sinusoidal Capillarization and arterial blood supply continuously proceed with the advance of the stages of hepatocarcinogenesis in the rat. Jpn. J. Cancer Res., 87: 442-450. 1996.
16. Rajewsky, M. F. Changes in DNA synthesis and cell proliferation during hepatocarcinogenesis by diethylnitrosamine. Eur. J. Cancer, 3: 335-342, 1967.
17. Rabes. H. M., and Szymkowiak, R. Cell kinetics of hepatocytes during the preneoplastic period of diethylnitrosamine-induced liver carcinogenesis. Cancer Res., 39: 1298-1304, 1979.
18. Gerolami, R., Cardoso, J., Bralet, M. P., Cuenod, C. A., Clement, O., Tran, P. L., and Brechot, C. Enhanced in vivo adenovirus-mediated gene transfer to rat hepatocarcinomas by selective administration into the hepatic artery. Gene Ther., 5: 896-904, 1998.
19. Bui, L. A., Butterfield, L. H., Kim, J. Y., Ribas, A., Seu, P., Lau, R., Glaspy, J. A., McBride, W. H., and Economou, J. S. In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing Interleukin-2. Hum. Gene Ther., 8: 2173-2182, 1997.
20. Arbuthnot, P. B., Bralet, M. P., Le Jossic, C., Dedieu, J. F., Perricaudet, M., Brechet, C., and Ferry, N. In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector. Hum. Gene Ther., 7: 1503-1514, 1996.
21. Ido, A., Nakata, K., Kato, Y., Nakao, K., Murata, K., Fujita, M., Ishii, N., Tamaoki, T., Shiku, H., and Nagataki, S. Gene therapy for hepatoma cells using retrovirus vector carrying Herpes Simplex virus thymidine kinase gene under the control of human α-fetoprotein gene promoter. Cancer Res., 55: 3105-3109, 1995.
22. Tran, P. L., Weinbach, J., Opolon, P., Linares-Cruz, G., Reynes, J. P., Gregoire, A., Kremer, E., Durand, H., and Perricaudet, M. Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene, J. Clin. Invest., 99: 608-617, 1997.
23. Rajewski, M. F., Dauber. W., and Frankenberg, H. Liver carcinogenesis by diethylnitrosamine in the rat. Science (Washington DC), 152: 83-85, 1966.
24. Steward, H. L., Williams, G., Keysser, C. H., and Montali, R. J. Histologic typing of liver tumors of the rat. J. Natl. Cancer Inst. 64: 180-190, 1980.
25. Kianmanesh, A. R., Perrin, H., Panis, Y., Fabre, M., Nagy, H. J., Houssin, D., and Klatzmann, D. A "distant" bystander effect of suicide gene therapy:regression of nontransduced tumors together with a distant transduced tumor. Hum. Gene Ther., 8: 1807-1814, 1997.
26. Wei. M. X., Bougnoux, P., Sacre-Salem, B., Peyrat, M. B., Lhuillery, C., Salzmann, J. L., and Klatzmann, D. Suicide gene therapy of chemically induced mammary tumor in rat: efficacy and distant bystander effect. Cancer Res., 58: 1529-1532, 1998.
27. Lafarge-Frayssinet, C., Huynh, T. D., Frayssinet, C., Sarasin, A., Anthony. D., Quo, Y., and Trojan. J. Antisense insulin-like growth factor I transferred into a rat hepatoma cell line inhibits tumorigenesis by modulating major histocompatibility complex I cell surface expression. Cancer Gene Ther., 4: 276-285, 1997.
28. Moolten, F. L. Drug sensitivity ("suicide") genes for selective cancer chemotherapy. Cancer Gene Ther., 4: 279-287, 1994.
29. Van der Erb, M. M., Cramer, S. J., Vergouwe, Y., Schagen, F. H. E., Van Krieken, J. H. J. M., Van der Eb, A., Borel Rinkes, I. H. M., Van der Velde, C. J. H., and Hoeben, R. C. Severe hepatic dysfunction after adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene and ganciclovir administration. Gene Ther. 5: 451-458, 1998.
30. Brand, K., Arnold, W., Bartels, T., Lieber, A., Kay, M. A., Strauss, M., and Dörken, B. Liver-associated toxicity of the HSV-tk/GCV approach and adenoviral vectors. Cancer Gene Ther., 4: 9-16, 1997.
31. Wallace, H., Clarke, A. R., Harrison, D. J., Hooper. M. L., and Bishop. J. O. Ganciclovir-induced ablation of non-proliferating thyrocytes expressing herpesvirus thymidine kinase occurs by p53-independent apoptosis. Oncogene, 13: 55-61, 1996.
32. Allen, R. G., Carey. C., Parker, J. D., Mortrud, M. T., Mellon, S. H., and Low, M. J. Targeted ablation of pituitary pre-proopiomelanocortin receptor and aldosterone synthase in the mouse adrenal gland. Mol. Endocrinol., 9: 1005-1016, 1995.
33. Ohguchi, S., Nakatzukasa, H., Higashi, T., Ashida, K., Nouso, K., Ishizaki, M., Hino, N., Konayashi, Y., Uematzu, S., and Tsuji, T. Expression of α-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy. Hepatology, 28: 599-607, 1998.
34. Bramson, J. L., Hitt, M., Gauldie, J., and Graham, F. L. Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination. Gene Ther, 4: 1069-1076, 1997.